Concepedia

Anna Shteingauz

AS

14

Publications

1.2K

Citations

14

H-Index

2009

Active since

Affiliations

Novocure (United States)(Current)

Rappaport Family Institute for Research in the Medical Sciences

Emcure Pharmaceuticals (India)

Rambam Health Care Campus

University of Lucerne

Anna Shteingauz is an author at Novocure (United States) specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2009–2022

14

Publications

14

Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells

Moshe Giladi, Rosa S. Schneiderman, Tali Voloshin et al. · Scientific Reports · 2015 · 303 citations · Full text

Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy

Anna Shteingauz, Ilanit Boyango, Inna Naroditsky et al. · Cancer Research · 2015 · 160 citations · Full text

, , +15

Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy

Tali Voloshin, Noa Kaynan, Shiri Davidi et al. · Cancer Immunology Immunotherapy · 2020 · 157 citations · Full text

Heparanase 2 Interacts with Heparan Sulfate with High Affinity and Inhibits Heparanase Activity

Flonia Levy‐Adam, Sari Feld, Victoria Cohen‐Kaplan et al. · Journal of Biological Chemistry · 2010 · 142 citations · Full text

, , +15

AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)

Anna Shteingauz, Yaara Porat, Tali Voloshin et al. · Cell Death and Disease · 2018 · 106 citations · Full text

Rows per page

1–5 of 14